Pancreatic ductal adenocarcinoma: Prognostic indicators of advanced disease

BACKGROUND/OBJECTIVES: Pancreatic ductal adenocarcinoma (PDAC) is an aggressive malignancy associated with high metastatic risk. Prognosis remains poor even after resection. Previously our group identified biomarkers that improved diagnostic accuracy in PDAC beyond the established diagnostic tumour...

Descripción completa

Detalles Bibliográficos
Autores principales: Kruger, Deirdré, Lahoud, Nicola, Yako, Yandiswa Y., Devar, John, Smith, Martin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2022
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8754286/
https://www.ncbi.nlm.nih.gov/pubmed/35020761
http://dx.doi.org/10.1371/journal.pone.0262439

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8754286/
https://www.ncbi.nlm.nih.gov/pubmed/35020761
http://dx.doi.org/10.1371/journal.pone.0262439

Ejemplares similares